Multimodal Imaging

Multimodal Imaging

Global Multimodal Imaging Market to Reach $3.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Multimodal Imaging estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at a CAGR of 4.3% over the analysis period 2020-2027. PET/CT Systems, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the SPECT/CT Systems segment is readjusted to a revised 3.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $624.7 Million, While China is Forecast to Grow at 7% CAGR

The Multimodal Imaging market in the U.S. is estimated at US$624.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$645 Million by the year 2027 trailing a CAGR of 7.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

PET/MR Systems Segment to Record 4.4% CAGR

In the global PET/MR Systems segment, USA, Canada, Japan, China and Europe will drive the 4.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$312.6 Million in the year 2020 will reach a projected size of US$414.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$410.9 Million by the year 2027, while Latin America will expand at a 4.6% CAGR through the analysis period.

Select Competitors (Total 42 Featured) -

  • Canon Medical Systems Corporation
  • Carl Zeiss AG
  • GE Healthcare
  • Heidelberg Engineering
  • Infraredx, Inc.
  • Koninklijke Philips N.V.
  • Mediso Medical Imaging Kft
  • MILabs B.V.
  • Neusoft Medical Systems Co., Ltd.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Siemens Healthineers
  • Spectrum Dynamics Medical
  • Topcon Corporation
  • United Imaging Healthcare Co., Ltd.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Multimodal Imaging Competitor Market Share Scenario Worldwide (in %): 2020E
Global Competitor Market Shares by Segment
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Multimodal Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Multimodal Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for PET/CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for PET/CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for PET/CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for SPECT/CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for SPECT/CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for SPECT/CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for PET/MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for PET/MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for PET/MR Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for OCT/Fundus Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for OCT/Fundus Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for OCT/Fundus Imaging Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 25: World Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 28: World Current & Future Analysis for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Brain & Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 31: World Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 34: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 35: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 37: World Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 38: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 40: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 41: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 42: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
Market Analytics
TABLE 43: USA Current & Future Analysis for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 44: USA Historic Review for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 45: USA 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies for the Years 2012, 2020 & 2027
TABLE 46: USA Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 47: USA Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 48: USA 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2012, 2020 & 2027
TABLE 49: USA Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 50: USA Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 51: USA 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
TABLE 52: Canada Current & Future Analysis for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 53: Canada Historic Review for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 54: Canada 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies for the Years 2012, 2020 & 2027
TABLE 55: Canada Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 56: Canada Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 57: Canada 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2012, 2020 & 2027
TABLE 58: Canada Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 59: Canada Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 60: Canada 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
TABLE 61: Japan Current & Future Analysis for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 62: Japan Historic Review for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 63: Japan 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies for the Years 2012, 2020 & 2027
TABLE 64: Japan Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 65: Japan Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 66: Japan 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2012, 2020 & 2027
TABLE 67: Japan Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 68: Japan Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 69: Japan 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
TABLE 70: China Current & Future Analysis for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 71: China Historic Review for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 72: China 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies for the Years 2012, 2020 & 2027
TABLE 73: China Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 74: China Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 75: China 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2012, 2020 & 2027
TABLE 76: China Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 77: China Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 78: China 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
Market Facts & Figures
Market Analytics
TABLE 79: Europe Current & Future Analysis for Multimodal Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 80: Europe Historic Review for Multimodal Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 81: Europe 15-Year Perspective for Multimodal Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 82: Europe Current & Future Analysis for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 83: Europe Historic Review for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 84: Europe 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies for the Years 2012, 2020 & 2027
TABLE 85: Europe Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 86: Europe Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 87: Europe 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2012, 2020 & 2027
TABLE 88: Europe Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 89: Europe Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 90: Europe 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
TABLE 91: France Current & Future Analysis for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 92: France Historic Review for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 93: France 15-Year Perspective for Multimodal Imaging by Technology - Percentage Breakdown of Value Sales for PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies for the Years 2012, 2020 & 2027
TABLE 94: France Current & Future Analysis for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 95: France Historic Review for Multimodal Imaging by Application - Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 96: France 15-Year Perspective for Multimodal Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Brain & Neurology and Ophthalmology for the Years 2012, 2020 & 2027
TABLE 97: France Current & Future Analysis for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 98: France Historic Review for Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 99: France 15-Year Perspective for Multimodal Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
TABLE 100: Germany Current & Future Analysis for Multimodal Imaging by Technology - PET/CT Systems, SPECT/CT Systems, PET/MR Systems, OCT/Fundus Imaging Systems and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook